Skip to main content

JPMORGAN CHASE & CO

Position in QNCX — Quince Therapeutics, Inc.

CIK 19617 NEW YORK, NY

Position in QNCX

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$9,473
-$304,757 QoQ
Shares Held
469
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 46 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in QNCX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $16,579,226,864 across 407 Biotechnology names. QNCX ranks #300 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in QNCX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $9,473 469
2025-12-31 $314,230 469
2025-09-30 $152,894 469
2025-06-30 $154,770 469
2025-03-31 $145,502 547
2024-12-31 $203,830 545
2024-09-30 $85,048 548
2024-06-30 $70,350 469
2024-03-31 $99,428 469
2023-12-31 $98,490 469
2023-09-30 $105,056 469
2023-06-30 $141,169 469
2023-03-31 $146,328 469
2022-12-31 $59,750 469
2022-09-30 $61,942,888 232,868
2022-06-30 $251,768,868 567,047
2022-03-31 $730,941,198 590,421
2021-12-31 $25,502,496 10,104
2021-09-30 $247,646,988 13,509
2021-06-30 $128,938,400 12,164
2021-03-31 $64,039,722 8,887
2020-12-31 $95,574,312 17,202
2020-09-30 $107,190,000 10,719
2020-06-30 $96,146,580 10,383
2020-03-31 $130,763,870 14,335